Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/07/2003US6630618 Transgenic plants having non-pathogen induced systemic acquired resistance (SAR)
10/07/2003US6630616 Arabidopsis MPC1 gene and methods for controlling flowering time
10/07/2003US6630615 Plants; gene expression; promoters; neoxanthin cleavage enzyme activity; genetic engineering; use of isolated nucleotide sequences to transform plants with genes that will enhance the resistance of the plants to diseases
10/07/2003US6630614 Genetic engineering; cassettes; transgenic plants; nucleotide sequences; polynucleotides; use in modulating Rad21 to regul-ate meiotic recombination and DNA double-strand break repair to improve production and quality of crops such as corn
10/07/2003US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants
10/07/2003US6630612 Transgenic mouse embryo; for use as a model in the treatment of drug abuse
10/07/2003US6630576 Mutated forms of hIL13 conjugated to cytotoxins are used to preferentially target diseased cells over non-diseased cells
10/07/2003US6630575 B7-H2 Polypeptides
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630573 Tau-conotoxin peptides
10/07/2003US6630571 Mammalian growth factor-7
10/07/2003US6630570 Of tumor cells and tissues; derived from vaso-active intestinal protein, somatostatin or neurotensin; methine/cyanine; useful for endoscopy
10/07/2003US6630513 Capable of lowering plasma cholesterol levels and inhibiting abnormal cell proliferation, such as in cervical adenocarcinoma
10/07/2003US6630455 Methods for inducing mucosal immune responses
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630445 Unglycosylated recombinant human alpha-fetoprotein made in a prokaryote (e.g., E. coli)
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630348 Single-chain insulin analog and a polynucleotide sequence encoding the analog
10/07/2003US6630346 Gene therapy for obesity
10/07/2003US6630345 Isolated DNA soup from amino acid sequence 1 or 2
10/07/2003US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells
10/07/2003US6630343 Hepatitis C virus culture system
10/07/2003US6630341 Phosphohexuloisomerase and gene therefor
10/07/2003US6630328 Increasing production of proteins in gram-positive microorganisms
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630325 Compositions, methods and kits relating to remodel
10/07/2003US6630323 Naked cuticle genes and their uses
10/07/2003US6630318 Prognostic evaluation of cancer
10/07/2003US6630317 Methods for obtaining, identifying and applying nucleic acid sequences and (poly)peptides which increase the expression yields of periplasmic proteins in functional form
10/07/2003US6630315 Adsorbing bacterial toxins by contacting with a material having an immobilizing carrier; use in detecting exotoxins in blood and urine and in treatment of sepsis and autoimmune diseases
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630305 Compositions and methods for the therapy and diagnosis of prostate cancer
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630298 HCV antigen/antibody combination assay
10/07/2003US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
10/07/2003US6630148 Amino acid sequence binds to naturally occurring patched receptor; generate and/or maintain an array of vertebrate tissue; expression of secondary signaling molecules, such as Transforming Growth Factors and fibroblast growth factors
10/07/2003US6630146 Candida albicans phosphomannan complex as a vaccine
10/07/2003US6630144 Monoclonal antibodies to Ebola glycoprotein
10/07/2003US6630143 Monoclonal antibodes, treating hematopoietic disorders, in particular, aplastic anemia and myelodysplastic syndromes
10/07/2003US6630142 Reducing cell proliferation; obtain sample, incubate with antagonist, monitor sample for reduced cell proliferation
10/07/2003US6630141 Purified DNA including a sequence encoding an Ikaros protein; Alzheimer's disease; differentiation and generation of T cells
10/07/2003US6630140 Compositions and methods for treatment of asthma
10/07/2003US6630124 Combination therapy with VIP antagonist
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2076320C Process for producing peptide
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/07/2003CA1341442C Transgenic animals
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081246A1 Treatment of congestive heart failure with natriuretic peptide and a diuretic
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080852A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
10/02/2003WO2003080841A1 Calcineurin activators
10/02/2003WO2003080840A1 A method of inspecting the genetic susceptibility of h.pylori related gastric carcinoma and the use of it
10/02/2003WO2003080839A2 Antigen fragments for the diagnosis of toxoplasma gondii
10/02/2003WO2003080838A1 Novel meloidogyne-resistance gene and utilization thereof
10/02/2003WO2003080837A1 Production of recombinant che a 1 allergen from chenopodium album and system of isolating and purifying same
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080828A2 Nucleic acid molecules involved in the synthesis of melithiazols
10/02/2003WO2003080824A1 Hapatitis b viral packaging system
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080805A2 Kinases and phosphatases
10/02/2003WO2003080800A2 Prevention and treatment of disease using angiogenesis-and/or tumor antigens
10/02/2003WO2003080799A2 Polymorphic repetitive sequences in chlamydiae and uses thereof
10/02/2003WO2003080797A2 6 human secreted proteins
10/02/2003WO2003080796A2 Ordered biological nanostructures formed from chaperonin polypeptides
10/02/2003WO2003080795A2 Novel nucleic acids and secreted polypeptides
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080669A2 Anti-hpv-16 e7 antibodies and their use
10/02/2003WO2003080668A1 NUCLEAR RECEPTOR RXRα ISOFORMS
10/02/2003WO2003080667A2 A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
10/02/2003WO2003080666A2 An adipocyte insulin and a method of treating diabetes
10/02/2003WO2003080665A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003WO2003080664A1 P-rex1, a ptdins (3, 4, 5) p3- g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
10/02/2003WO2003080663A2 Tenascin-w compositions and uses thereof
10/02/2003WO2003080662A1 Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
10/02/2003WO2003080661A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
10/02/2003WO2003080660A2 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
10/02/2003WO2003080659A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003WO2003080658A1 Novel allergen
10/02/2003WO2003080657A2 Yeast pheromones for the treatment of infectious diseases
10/02/2003WO2003080656A1 Novel bacillus thuringiensis insecticidal proteins
10/02/2003WO2003080655A1 A mutated immunoglobulin-binding protein
10/02/2003WO2003080654A2 Helicobacter flagellar, motility polypeptides
10/02/2003WO2003080653A1 Novel polypeptide scaffolds and use thereof
10/02/2003WO2003080652A1 Antimicrobial peptide, its analogs and antimicrobial composition comprising them
10/02/2003WO2003080646A2 Modified plasminogen activator inhibitor type-1 and methods based thereon
10/02/2003WO2003080644A2 Novel method for the direct and regulated transfer of genetic material between cells
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 2916